Junichi Shimada - Concepedia

Author

Junichi Shimada

Also Known As

Hiroshi Natori, J SHIMADA, J Shimada, J. SHIMADA, J. Shimada, JUNICHI SHIMADA, Jun'ichi Shimada, Jun-Ichi Shimada, Jun-ichi SHIMADA, Jun-ichi Shimada

280

Publications

3.5K

Citations

H-Index

183

Concepts

All Affiliations

Kyowa Kirin (Japan)Kyoto Prefectural University of Medicine Tokyo Metropolitan Institute of Gerontology Electrotechnical Institute Tokyo Medical and Dental University

About

Junichi Shimada is an author at Kyowa Kirin (Japan) specializing in medicine, engineering, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	37	1.6K
2	Engineering	19	29	900
3	Natural Sciences	6	6	327
4	Health Sciences	5	5	168
5	Education	1	1	20

Junichi Shimada

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase Ho Jeong Kwon, Takashi Owa, Christian A. Hassig, Proceedings of the National Academy of Sciences	1998	195
KF17837: A novel selective adenosine A2A receptor antagonist with anticataleptic activity Tomoyuki Kanda, Shizuo Shiozaki, Junichi Shimada, European Journal of Pharmacology Molecular PharmacologyFunctional SelectivityMedicineMechanism Of ActionReceptor (Biochemistry)	1994	146
(E)-1,3-Dialkyl-7-methyl-8-(3,4,5-trimethoxystyryl)xanthines: potent and selective adenosine A2 antagonists Junichi Shimada, Fumio Suzuki, Hiromi Nonaka, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapySystem PharmacologyChemical BiologyPharmaceutical Chemistry	1992	138
Clinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer Satoru Okada, Junichi Shimada, Daishiro Kato, The Annals of Thoracic Surgery Surgical OncologyPrognostic Nutritional IndexMedicineCancer ManagementPrognosis	2017	134
Adenosine A2A antagonists with potent anti-cataleptic activity Junichi Shimada, Nobuaki Koike, Hiromi Nonaka, Bioorganic & Medicinal Chemistry Letters MedicineAdenosine A2aPharmacotherapyAnesthesiaPharmacology	1997	106
Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin Tsunehiro Ii, Yoshiko Satomi, Daishiro Katoh, Cancer Letters Tumor BiologyMedicineCell Cycle ArrestCell CycleTumor Suppressor	2003	100
Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure Fumio Suzuki, Junichi Shimada, Hideaki Mizumoto, Journal of Medicinal Chemistry	1992	91
Classification of hydrocephalus and outcome of treatment Koreaki Mori, Junichi Shimada, Masahiro Kurisaka, Brain and Development Neuro-oncologyPediatric HydrocephalusBrain InjuryNeurologyBrain Lesion	1995	89
The mechanism of oxidative degradation of ABS resin. Part I. The mechanism of thermooxidative degradation Junichi Shimada, Kimiaki Kabuki Journal of Applied Polymer Science EngineeringOxidation ResistanceOxidative DegradationGreen ChemistryFilm Samples	1968	89
Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-[(R)-phenylisopropyl]adenosine-induced cognitive disturbance Fumio Suzuki, Junichi Shimada, Shizuo Shiozaki, Journal of Medicinal Chemistry Molecular PharmacologyAdenosine A1 AntagonistsNeuropeptidesBiochemistryFunctional Selectivity	1993	79

Page 1